Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine.
Open Access
- 1 February 1982
- journal article
- Published by Wiley
- Vol. 13 (2) , 177-185
- https://doi.org/10.1111/j.1365-2125.1982.tb01353.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.Circulation, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Two new metabolites of sulfinpyrazone in the rabbit: A possible cause of the prolonged
- Noncompartmental Determination of the Steady‐State Volume of DistributionJournal of Pharmaceutical Sciences, 1979
- ESTRIP, a BASIC Computer Program for Obtaining Initial Polyexponential Parameter EstimatesJournal of Pharmaceutical Sciences, 1978
- The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivoThrombosis Research, 1978
- Quantitative assay of sulphinpyrazone in plasma and urine by high-performance liquid chromatographyJournal of Chromatography A, 1976
- Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan®) in manEuropean Journal of Clinical Pharmacology, 1975
- Arteriovenous-Shunt ThrombosisNew England Journal of Medicine, 1974
- Observations on G-25671, A Phenylbutazone Analogue (4-(phenylthioethyl) -1,2-diphenyl 3,5-pyrazolidinedione).Experimental Biology and Medicine, 1954